Deal Announcement 07/19: Chemicals

PwC acted as exclusive financial advisor to funds advised by Orlando Management AG on the sale of Solvachem sp. z o.o, a Poland-based distributor of chemical admixtures, to the management team in a combined MBI/ MBO.

The Deal

The PwC M&A team is pleased to announce the successful Closing of Project Blue Poland, the sale of Solvachem sp. z o.o (“Solvachem”), a Poland-based subsidiary of Saldovis Holding S.à.r.l. (“Saldovis”), to VIA WEST spółka z ograniczoną odpowiedzialnością (“Via West”), an MBI/ MBO vehicle. Solvachem was a portfolio company of Special Situations Venture Partners II funds, which are exclusively advised by Orlando Management AG. PwC M&A acted as exclusive financial advisor to the Vendor on this transaction.

The share purchase agreement for Solvachem was signed on 27th May 2019 and the transaction was closed within the same week.


Solvachem is a Poland-based subsidiary of Saldovis. Solvachem serves customers in various industries by distributing chemical admixtures ranging from base products to special active substances, as well as raw materials. In 2018, Solvachem generated revenues of approx. € 60m with more than 20 employees.

Solvachem was formerly part of the Solvadis Group, a Germany-based top tier European chemicals distribution and marketing company, which was acquired by Sojitz, a leading Japanese trading company, in 2017.

Via West

Via West is a vehicle formed for the combined management buy-in (“MBI”) and management buy-out (“MBO”) of this transaction.


The global PricewaterhouseCoopers network is a worldwide association of independent auditing and consulting companies which together employ more than 250,000 people in 158 countries. Our global network comprises nearly 1,550 M&A professionals all over the world, realising approx. 400 successful transactions per year. We specialise in a wide range of independent M&A services including advice on acquisitions and disposals, mergers, public takeovers, privatisations as well as structured financing.

PwC M&A Germany acted as exclusive financial advisor to the Vendor on this transaction. The transaction was led by Alexander Wenzel (Partner) and supported by Nils Werner (Associate).

Deal Announcement 07/19: Chemicals

Contact us

Dr. Alexander von Friesen

Dr. Alexander von Friesen

Partner, Corporate Finance | M&A Healthcare & Consumer, PwC Germany

Tel: +49 151 11714398

Follow us